Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, X-Linked

Explore clinical trials studying Genetic Diseases, X-Linked. Study availability and eligibility vary by location and protocol.

1,243 public trials 227 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, X-Linked trial results

Completed

Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

NCT03614234

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • UAB Medicine Birmingham, Alabama, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinica Iowa City, Iowa, United States
  • Infusion Associates Grand Rapids, Michigan, United States
View all 14 locations
View Trial Details
Completed

Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain

NCT02450604

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +25 more
Locations
  • Cs douleur chronique GHSR, CHU Sud Réunion Saint-Pierre, La Réunion, France
  • CeRCa, Unité de Neuromyologie, CHU de Fort de France FORT de France, Martinique, France
  • Centre Douleurs Chroniques, CH de la Côte Basque Bayonne, France
  • Centre Douleurs Chroniques, CHU de Bordeaux Bordeaux, France
View all 21 locations
View Trial Details
Completed

Esketamine for the Treatment of Rett Syndrome

NCT06199700

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations
  • Xiamen Children's Hospital (Children's Hospital of Fudan University at Xiamen) Xiamen, Fujian, China
View Trial Details
Completed

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

NCT05282953

Conditions
Choroid Diseases, Choroideremia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Save Sight Institute Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Harley Eye Clinic North Adelaide, South Australia, Australia
View Trial Details
Completed

Post-marketing Surveillance (Use Result Surveillance) With Refixia®

NCT03875547

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Søborg, Denmark
  • Nagoya University Hospital_Blood Transfusion Aichi, Japan
  • Aomori Prefectural Central Hospital_Pediatrics Aomori, Japan
  • Matsudo City General Hospital_Pediatrics Chiba, Japan
View all 23 locations
View Trial Details
Completed

Muscle Oxygenation in Effort in Neuromuscular Diseases

NCT02789059

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations
  • Hôpital Amiens Nord, Service de Neurologie Amiens, France
  • CHRU de Lille, Hôpital Swyngedhauw Lille, France
  • Hôpital Sébastopol, CHU de Reims Reims, France
View Trial Details

Related conditions